Live Breaking News & Updates on Authorized generics

Stay informed with the latest breaking news from Authorized generics on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Authorized generics and stay connected to the pulse of your community

How Drug Companies Use Authorized Generics To Keep Drug Prices High

While authorized generics are not unique to Flovent, its use in keeping the cost of asthma inhalers high is emblematic of the broader issue with this category.

United-states , American , Bernie-sanders , Congressional-budget-office , American-rescue-plan-act , Glaxosmithkline , Medicaid , Asthma , Inhalers , Authorized-generics ,

Authorized Generics In The US: Prevalence, Characteristics, And Timing, 2010–19

Authorized Generics In The US: Prevalence, Characteristics, And Timing, 2010–19
healthaffairs.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healthaffairs.org Daily Mail and Mail on Sunday newspapers.

United-states , American , Michael-folkendt , Cheryl-kaiser , Sydnie-parr , Rinku-patel , Martin-shimer , Annabelle-fowler , Us-supreme-court , Drug-administration , Oak-ridge-institute-for-science , National-drug-code

Authorized Generics In The US: Prevalence, Characteristics, And Timing, 2010–19

Authorized Generics In The US: Prevalence, Characteristics, And Timing, 2010–19
healthaffairs.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healthaffairs.org Daily Mail and Mail on Sunday newspapers.

United-states , American , Martin-shimer , Sydnie-parr , Annabelle-fowler , Cheryl-kaiser , Rinku-patel , Michael-folkendt , Research-fellowship-program , Public-health-strategy , Supreme-court , Department-of-energy

Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2022 Financial Results and Provides 2023 Financial Guidance

/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the full year and fourth quarter of 2022 and provided financial...

France , Germany , Japan , United-states , United-kingdom , Italy , Ireland , Russia , Dublin , Spain , Ukraine , Kristin-bhavnani

Jazz Pharmaceuticals plc: Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2022 Financial Results and Provides 2023 Financial Guidance

Strong Execution Drove Record Revenues in 2022 of $3.7 billion, an increase of 18% over 2021Positioned for Total Revenue and Net Income Growth in 2023 Xywav Enters 2023 as the Oxybate Therapy

France , Germany , Japan , United-states , United-kingdom , Italy , Ireland , Russia , Dublin , Spain , Ukraine , Dennis-riedl

Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2022 Financial Results and Provides 2023 Financial Guidance

/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the full year and fourth quarter of 2022 and provided financial...

France , Germany , Japan , United-states , United-kingdom , Italy , Ireland , Russia , Dublin , Spain , Ukraine , Kristin-bhavnani

Alfasigma Says Westminster Pharmaceuticals Committed Tortious Interference with Contract in Suit Over Medical Foods

A complaint filed Monday in Tampa, Florida by Alfasigma USA Inc., formerly known as Nestlé Health Science Pamlab Inc., claims that Westminster

Florida , United-states , Carlton , Tennessee , Tampa , Alfasigma-united-states-inc , Health-science-pamlab-inc , Shearman-sterling , Westminster-pharmaceuticals , Virtus-pharmaceuticals-inc , Business-development

Elite Pharmaceuticals, Inc.: Elite Pharmaceuticals Enters into an Exclusive Distribution Agreement with Prasco, LLC and Announces Commercial Launch of Loxapine Capsules

(1)
NORTHVALE, NJ / ACCESSWIRE / May 4, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today that its distribution and marketing partner Prasco, LLC ("Prasco"), has launched Elite's generic Loxapine capsules.
Elite entered a license, supply, and distribution agreement ("Agreement") with Prasco for Elite's Abbreviated New Drug Application (ANDA) for Loxapine Succinate capsules, 5 mg, 10 mg, 25 mg, and 50 mg ("Loxapine Capsules"). Loxapine is indicated for the treatment of schizophrenia and is currently listed on the FDA drug shortage list.
Prasco will be the exclusive U.S. distributor for Loxapine capsules, which will be marketed under Burel Pharmaceutical's label. Under the Agreement, Prasco will provide sales, marketing, and distribution for the product, and Elite will manufacture the product.

Ohio , United-states , Nasrat-hakim , Chris-arington , Exchange-commission , Lannett-company , Pharmaceuticals-inc , Glenmark-pharmaceuticals-inc , Elite-pharmaceuticals , Abbreviated-new-drug-application , Loxapine-succinate , Burel-pharmaceutical

Elite Pharmaceuticals Enters into an Exclusive Distribution Agreement with Prasco, LLC and Announces Commercial Launch of Loxapine Capsules

Elite Pharmaceuticals Enters into an Exclusive Distribution Agreement with Prasco, LLC and Announces Commercial Launch of Loxapine Capsules
ACCESSWIRE
05 May 2021, 00:31 GMT+10
NORTHVALE, NJ / ACCESSWIRE / May 4, 2021 / Elite Pharmaceuticals, Inc. ('Elite' or the 'Company') (OTCBB:ELTP) announced today that its distribution and marketing partner Prasco, LLC ('Prasco'), has launched Elite's generic Loxapine capsules.
Elite entered a license, supply, and distribution agreement ('Agreement') with Prasco for Elite's Abbreviated New Drug Application (ANDA) for Loxapine Succinate capsules, 5 mg, 10 mg, 25 mg, and 50 mg ('Loxapine Capsules'). Loxapine is indicated for the treatment of schizophrenia and is currently listed on the FDA drug shortage list.
Prasco will be the exclusive U.S. distributor for Loxapine capsules, which will be marketed under Burel Pharmaceutical's label. Under the Agreement, Prasco will provide sales, marketing, and distribution for the product, and Elite will manufacture the product.

Ohio , United-states , Nasrat-hakim , Chris-arington , Exchange-commission , Lannett-company , Pharmaceuticals-inc , Glenmark-pharmaceuticals-inc , Elite-pharmaceuticals , Abbreviated-new-drug-application , Loxapine-succinate , Loxapine-capsules